Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.67 USD | -0.21% | -4.56% | -5.02% |
Financials (USD)
Sales 2024 * | 2.71M | Sales 2025 * | 2.66M | Capitalization | 2.48B |
---|---|---|---|---|---|
Net income 2024 * | -153M | Net income 2025 * | -196M | EV / Sales 2024 * | 915 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 934 x |
P/E ratio 2024 * |
-16.3
x | P/E ratio 2025 * |
-13.1
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | -0.21% | ||
1 week | -4.56% | ||
Current month | +0.67% | ||
1 month | -0.82% | ||
3 months | -0.13% | ||
6 months | +34.49% | ||
Current year | -5.02% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry Penner
BRD | Director/Board Member | 78 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +11.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 37.67 | -0.21% | 403,532 |
24-05-20 | 37.75 | -1.20% | 504,943 |
24-05-17 | 38.21 | -4.33% | 463,536 |
24-05-16 | 39.94 | -0.57% | 950,952 |
24-05-15 | 40.17 | +1.77% | 472,678 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.02% | 2.48B | |
+44.48% | 55.07B | |
+43.74% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- CLDX Stock